A regulatory feedback loop between HIF-1α and PIM2 in HepG2 cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yu, Zhenhai ^a   Zhao, Xiaoping ^b   Ge, Yingying ^c   Zhang, Teng ^b   Huang, Liangqian ^d   Zhou, Xiang ^b   Xie, Lei ^b   Liu, Jianjun ^b   Huang, Gang ^a,b,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PIM2 PROTEIN; PROTEIN SERINE THREONINE KINASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR DYNAMICS; ONCOGENE; PIM2 GENE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SURVIVAL RATE; TRANSACTIVATION;

CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 84895549790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088301     Document Type: Article

References (52)

1. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
2. Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309.
3. Semenza GL (2011) Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 76: 347-353.
4. Bader HL, Hsu T (2012) Systemic VHL gene functions and the VHL disease. FEBS Lett 586: 1562-1569.
5. Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, et al. (2008) Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett 266: 12-20.
6. Wu D, Zhang R, Zhao R, Chen G, Cai Y, et al. (2013) A novel function of novobiocin: disrupting the interaction of HIF 1alpha and p300/CBP through direct binding to the HIF1alpha C-terminal activation domain. PLoS ONE 8: e62014.
7. Giatromanolaki A, Koukourakis MI, Pezzella F, Turley H, Sivridis E, et al. (2008) Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Lett 262: 87-93.
8. Semenza GL (2013) Advances in cancer biology and therapy. J Mol Med (Berl) 91: 409.
9. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, et al. (2010) Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A 107: 12722-12727.
10. van der Lugt NM, Domen J, Verhoeven E, Linders K, van der Gulden H, et al. (1995) Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J 14: 2536-2544.
11. Narlik-Grassow M, Blanco-Aparicio C, Carnero A (2014) The PIM Family of Serine/Threonine Kinases in Cancer. Med Res Rev 34: 136-159.
12. Blanco-Aparicio C, Carnero A (2013) Pim kinases in cancer: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol 85: 629-643.
13. Zhang Y, Wang Z, Li X, Magnuson NS (2008) Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 27: 4809-4819.
14. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N (2008) Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27(Kip1) at the transcriptional and posttranscriptional levels. Cancer Research 68: 5076-5085.
15. Yan B, Zemskova M, Holder S, Chin V, Kraft A, et al. (2003) The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 278: 45358-45367. (Pubitemid 37432672)
16. Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P (2013) The Warburg effect: insights from the past decade. Pharmacol Ther 137: 318-330.
17. Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, et al. (2004) Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 24: 6104-6115. (Pubitemid 38787993)
18. Lu J, Zavorotinskaya T, Dai Y, Niu XH, Castillo J, et al. (2013) Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation. Blood 122: 1610-1620.
19. Yuan LL, Green AS, Bertoli S, Grimal F, Mansat-De Mas V, et al. (2013) Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia. Leukemia 10: 1038.
20. Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, et al. (2005) Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate 65: 276-286. (Pubitemid 41443733)
21. Ding G, Liu HD, Liang HX, Ni RF, Ding ZY, et al. (2013) HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation. FEBS Lett 587: 930-935.
22. Yu Z, Zhao X, Huang L, Zhang T, Yang F, et al. (2013) Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells. J Biol Chem 288: 35406-35416.
23. Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, et al. (2012) Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 122: 2417-2427.
24. Jain S, Maltepe E, Lu MM, Simon C, Bradfield CA (1998) Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 73: 117-123. (Pubitemid 28218548)
25. Yang J, Wang J, Chen K, Guo G, Xi R, et al. (2013) eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes. Cancer Res 73: 4898-4908.
26. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537.
27. Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732-744.
28. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, et al. (2007) The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 21: 1037-1049. (Pubitemid 46686473)
29. Huang LE (2013) Biochemistry. How HIF-1alpha handles stress. Science 339: 1285-1286.
30. Burgess DJ (2012) Cancer genetics: HIF enhances its reputation. Nat Rev Cancer 12: 316.
31. Zirkin S, Davidovich A, Don J (2013) The PIM-2 kinase is an essential component of the ultraviolet damage response that acts upstream to E2F-1 and ATM. J Biol Chem 288: 21770-21783.
32. Zhukova Iu N, Alekseeva MG, Zakharevich NV, Shtil AA, Danilenko VN (2011) [The Pim family of protein kinases: structure, functions and roles in hematopoietic malignancies]. Mol Biol (Mosk) 45: 755-764.
33. Seton-Rogers S (2011) Hypoxia: HIF switch. Nat Rev Cancer 11: 391.
34. Tan M, Gu Q, He H, Pamarthy D, Semenza GL, et al. (2008) SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. Oncogene 27: 1404-1411. (Pubitemid 351317467)
35. Luo W, Chang R, Zhong J, Pandey A, Semenza GL (2012) Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc Natl Acad Sci U S A 109: E3367-3376.
36. Kim SH, Xia D, Kim SW, Holla V, Menter DG, et al. (2010) Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res 70: 4054-4063.
37. Bergeron D, Poliquin L, Kozak CA, Rassart E (1991) Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. J Virol 65: 7-15.
38. Saris CJ, Domen J, Berns A (1991) The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 10: 655-664. (Pubitemid 21905520)
39. Chen LS, Redkar S, Bearss D, Wierda WG, Gandhi V (2009) Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. Blood 114: 4150-4157.
40. Chen LS, Redkar S, Taverna P, Cortes JE, Gandhi V (2011) Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia. Blood 118: 693-702.
41. Agrawal-Singh S, Koschmieder S, Gelsing S, Stocking C, Stehling M, et al. (2010) Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model. Blood 115: 4507-4516.
42. Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, et al. (2008) Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111: 750-760.
43. Tahvanainen J, Kylaniemi MK, Kanduri K, Gupta B, Lahteenmaki H, et al. (2013) Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation. J Biol Chem 288: 3048-3058.
44. Asano J, Nakano A, Oda A, Amou H, Hiasa M, et al. (2011) The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells. Leukemia 25: 1182-1188.
45. Neri P, Bahlis NJ (2013) Pinning down myeloma with Pim2 inhibitors! Blood 122: 1534-1536.
46. Brault L, Menter T, Obermann EC, Knapp S, Thommen S, et al. (2012) PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. Br J Cancer 107: 491-500.
47. Gomez-Abad C, Pisonero H, Blanco-Aparicio C, Roncador G, Gonzalez-Menchen A, et al. (2011) PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood 118: 5517-5527.
48. Levy D, Davidovich A, Zirkin S, Frug Y, Cohen AM, et al. (2012) Activation of Cell Cycle Arrest and Apoptosis by the Proto-Oncogene Pim-2. PLoS One 7.
49. Ren K, Gou X, Xiao M, Wang M, Liu C, et al. (2013) The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B. Prostate 73: 1462-1469.
50. Wang Z, Zhang Y, Gu JJ, Davitt C, Reeves R, et al. (2010) Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells. Int J Biochem Cell Biol 42: 1030-1038.
51. Gong JP, Wang JJ, Ren K, Liu CA, Li B, et al. (2009) Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction Through Mediating Survival and Preventing Apoptosis of Liver Cell. Journal of Surgical Research 153: 17-22.
52. Ren K, Zhang W, Shi YJ, Gong JP (2010) Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-kappa B Pathway. Pathol Oncol Res 16: 229-237.